The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes
PINK1 (phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-induced kinase 1), a Parkinson’s disease-associated gene, was identified originally because of its induction by the tumor-suppressor PTEN. PINK1 promotes cell survival and potentially metastatic functions and protects against cell...
Gespeichert in:
Veröffentlicht in: | Oncogene 2015-03, Vol.34 (11), p.1363-1374 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1374 |
---|---|
container_issue | 11 |
container_start_page | 1363 |
container_title | Oncogene |
container_volume | 34 |
creator | O'Flanagan, C H Morais, V A Wurst, W De Strooper, B O'Neill, C |
description | PINK1 (phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-induced kinase 1), a Parkinson’s disease-associated gene, was identified originally because of its induction by the tumor-suppressor PTEN. PINK1 promotes cell survival and potentially metastatic functions and protects against cell stressors including chemotherapeutic agents. However, the mechanisms underlying PINK1 function in cancer cell biology are unclear. Here, using several model systems, we show that PINK1 deletion significantly reduced cancer-associated phenotypes including cell proliferation, colony formation and invasiveness, which were restored by human PINK1 overexpression. Results show that PINK1 deletion causes major defects in cell cycle progression in immortalized mouse embryonic fibroblasts (MEFs) from PINK1
−/−
mice, and in BE(2)-M17 cells stably transduced with short hairpin RNA against PINK1. Detailed cell cycle analyses of MEF cell lines from several PINK1
−/−
mice demonstrate an increased proportion of cells in G2/M and decreased number of cells in G1 following release from nocodazole block. This was concomitant with increased double and multi-nucleated cells, a reduced ability to undergo cytokinesis and to re-enter G1, and significant alterations in cell cycle markers, including failure to increase cyclin D1, all indicative of mitotic arrest. PINK1
−/−
cells also demonstrated ineffective cell cycle exit following serum deprivation. Cell cycle defects associated with PINK1 deficiency occur at points critical for cell division, growth and stress resistance in cancer cells were rescued by ectopic expression of human PINK1 and demonstrated PINK1 kinase dependence. The importance of PINK1 for cell cycle control is further supported by results showing that cell cycle deficits induced by PINK1 deletion were linked mechanistically to aberrant mitochondrial fission and its regulation by dynamin-related protein-1 (Drp1), known to be critical for progression of mitosis. Our data indicate that PINK1 has tumor-promoting properties and demonstrates a new function for PINK1 as a regulator of the cell cycle. |
doi_str_mv | 10.1038/onc.2014.81 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1668253297</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A406163896</galeid><sourcerecordid>A406163896</sourcerecordid><originalsourceid>FETCH-LOGICAL-c617t-1c4aa8ea093862540b86c8d4a354fbd63014948bf9b8a589fdad989806a1e5fe3</originalsourceid><addsrcrecordid>eNp9kctu1TAQhi0EoofCqnsUqZtKkIPvsZdVVaCialmUteU4kzQlsU_tZHF2fQ1ejyfB4ZRLUYW8sDzzzfif-RE6IHhNMFPvgndriglfK_IErQivZCmE5k_RCmuBS00Z3UMvUrrBGFca0-doj3KpiBbVCnVX11B8tvFr71Pw3---paIDn0NnF59IEaGbBztBKhwMQ-G2boBiE0MXIaU--ML6ZnmP4SdjvYNY2pSC63NVTl2DD9N2A-kletbaIcGr-3sffXl_enXysTy__HB2cnxeOkmqqSSOW6vAYs2UpILjWkmnGm6Z4G3dSJbn1FzVra6VFUq3jW200gpLS0C0wPbR0a5vVnU7Q5rM2KdFvPUQ5mSIlIoKRnWV0cN_0JswR5_VGcoYkSTvi_yPyr3yIkmG_1CdHcD0vg1TtG752hxzLIlkSstMrR-h8mlg7F3w0PY5_qDgza7AxZBShNZsYj_auDUEm8V8k803i_lGLVJf30ud6xGa3-wvtzPwdgeknPIdxL9meaTfD59Ct34</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1662461233</pqid></control><display><type>article</type><title>The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Nature Journals Online</source><source>SpringerLink Journals - AutoHoldings</source><creator>O'Flanagan, C H ; Morais, V A ; Wurst, W ; De Strooper, B ; O'Neill, C</creator><creatorcontrib>O'Flanagan, C H ; Morais, V A ; Wurst, W ; De Strooper, B ; O'Neill, C</creatorcontrib><description>PINK1 (phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-induced kinase 1), a Parkinson’s disease-associated gene, was identified originally because of its induction by the tumor-suppressor PTEN. PINK1 promotes cell survival and potentially metastatic functions and protects against cell stressors including chemotherapeutic agents. However, the mechanisms underlying PINK1 function in cancer cell biology are unclear. Here, using several model systems, we show that PINK1 deletion significantly reduced cancer-associated phenotypes including cell proliferation, colony formation and invasiveness, which were restored by human PINK1 overexpression. Results show that PINK1 deletion causes major defects in cell cycle progression in immortalized mouse embryonic fibroblasts (MEFs) from PINK1
−/−
mice, and in BE(2)-M17 cells stably transduced with short hairpin RNA against PINK1. Detailed cell cycle analyses of MEF cell lines from several PINK1
−/−
mice demonstrate an increased proportion of cells in G2/M and decreased number of cells in G1 following release from nocodazole block. This was concomitant with increased double and multi-nucleated cells, a reduced ability to undergo cytokinesis and to re-enter G1, and significant alterations in cell cycle markers, including failure to increase cyclin D1, all indicative of mitotic arrest. PINK1
−/−
cells also demonstrated ineffective cell cycle exit following serum deprivation. Cell cycle defects associated with PINK1 deficiency occur at points critical for cell division, growth and stress resistance in cancer cells were rescued by ectopic expression of human PINK1 and demonstrated PINK1 kinase dependence. The importance of PINK1 for cell cycle control is further supported by results showing that cell cycle deficits induced by PINK1 deletion were linked mechanistically to aberrant mitochondrial fission and its regulation by dynamin-related protein-1 (Drp1), known to be critical for progression of mitosis. Our data indicate that PINK1 has tumor-promoting properties and demonstrates a new function for PINK1 as a regulator of the cell cycle.</description><identifier>ISSN: 0950-9232</identifier><identifier>EISSN: 1476-5594</identifier><identifier>DOI: 10.1038/onc.2014.81</identifier><identifier>PMID: 24681957</identifier><identifier>CODEN: ONCNES</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/420/755 ; 692/699/67 ; Animals ; Apoptosis ; Cancer ; Cell Biology ; Cell cycle ; Cell division ; Cell Division - genetics ; Cell Line, Tumor ; Cell Movement ; Cell proliferation ; Cell Proliferation - genetics ; Cell survival ; Cellular biology ; Chemotherapy ; Chromosome 10 ; Clonal deletion ; Cyclin D1 ; Cyclin D1 - biosynthesis ; Cytokinesis ; Cytokinesis - genetics ; Dynamin ; Ectopic expression ; Embryo fibroblasts ; Embryos ; Gene Expression Regulation, Neoplastic - genetics ; Genetic aspects ; Genotype & phenotype ; GTP Phosphohydrolases - metabolism ; HeLa Cells ; Human Genetics ; Humans ; Internal Medicine ; Invasiveness ; Kinases ; M Phase Cell Cycle Checkpoints - genetics ; MCF-7 Cells ; Medicine ; Medicine & Public Health ; Metastases ; Mice ; Mice, Knockout ; Microtubule-Associated Proteins - metabolism ; Mitochondria ; Mitochondria - genetics ; Mitochondria - pathology ; Mitochondrial Proteins - metabolism ; Mitosis ; Movement disorders ; Neoplasm Invasiveness - genetics ; Neurodegenerative diseases ; Nocodazole ; Oncology ; original-article ; Parkinson Disease - genetics ; Parkinson's disease ; Phenotypes ; Protein Kinases - biosynthesis ; Protein Kinases - genetics ; Protein Kinases - metabolism ; PTEN protein ; Ribonucleic acid ; Risk factors ; RNA ; RNA Interference ; RNA, Small Interfering</subject><ispartof>Oncogene, 2015-03, Vol.34 (11), p.1363-1374</ispartof><rights>Macmillan Publishers Limited 2015</rights><rights>COPYRIGHT 2015 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Mar 12, 2015</rights><rights>Macmillan Publishers Limited 2015.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c617t-1c4aa8ea093862540b86c8d4a354fbd63014948bf9b8a589fdad989806a1e5fe3</citedby><cites>FETCH-LOGICAL-c617t-1c4aa8ea093862540b86c8d4a354fbd63014948bf9b8a589fdad989806a1e5fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/onc.2014.81$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/onc.2014.81$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,778,782,27911,27912,41475,42544,51306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24681957$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>O'Flanagan, C H</creatorcontrib><creatorcontrib>Morais, V A</creatorcontrib><creatorcontrib>Wurst, W</creatorcontrib><creatorcontrib>De Strooper, B</creatorcontrib><creatorcontrib>O'Neill, C</creatorcontrib><title>The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes</title><title>Oncogene</title><addtitle>Oncogene</addtitle><addtitle>Oncogene</addtitle><description>PINK1 (phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-induced kinase 1), a Parkinson’s disease-associated gene, was identified originally because of its induction by the tumor-suppressor PTEN. PINK1 promotes cell survival and potentially metastatic functions and protects against cell stressors including chemotherapeutic agents. However, the mechanisms underlying PINK1 function in cancer cell biology are unclear. Here, using several model systems, we show that PINK1 deletion significantly reduced cancer-associated phenotypes including cell proliferation, colony formation and invasiveness, which were restored by human PINK1 overexpression. Results show that PINK1 deletion causes major defects in cell cycle progression in immortalized mouse embryonic fibroblasts (MEFs) from PINK1
−/−
mice, and in BE(2)-M17 cells stably transduced with short hairpin RNA against PINK1. Detailed cell cycle analyses of MEF cell lines from several PINK1
−/−
mice demonstrate an increased proportion of cells in G2/M and decreased number of cells in G1 following release from nocodazole block. This was concomitant with increased double and multi-nucleated cells, a reduced ability to undergo cytokinesis and to re-enter G1, and significant alterations in cell cycle markers, including failure to increase cyclin D1, all indicative of mitotic arrest. PINK1
−/−
cells also demonstrated ineffective cell cycle exit following serum deprivation. Cell cycle defects associated with PINK1 deficiency occur at points critical for cell division, growth and stress resistance in cancer cells were rescued by ectopic expression of human PINK1 and demonstrated PINK1 kinase dependence. The importance of PINK1 for cell cycle control is further supported by results showing that cell cycle deficits induced by PINK1 deletion were linked mechanistically to aberrant mitochondrial fission and its regulation by dynamin-related protein-1 (Drp1), known to be critical for progression of mitosis. Our data indicate that PINK1 has tumor-promoting properties and demonstrates a new function for PINK1 as a regulator of the cell cycle.</description><subject>692/420/755</subject><subject>692/699/67</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Cancer</subject><subject>Cell Biology</subject><subject>Cell cycle</subject><subject>Cell division</subject><subject>Cell Division - genetics</subject><subject>Cell Line, Tumor</subject><subject>Cell Movement</subject><subject>Cell proliferation</subject><subject>Cell Proliferation - genetics</subject><subject>Cell survival</subject><subject>Cellular biology</subject><subject>Chemotherapy</subject><subject>Chromosome 10</subject><subject>Clonal deletion</subject><subject>Cyclin D1</subject><subject>Cyclin D1 - biosynthesis</subject><subject>Cytokinesis</subject><subject>Cytokinesis - genetics</subject><subject>Dynamin</subject><subject>Ectopic expression</subject><subject>Embryo fibroblasts</subject><subject>Embryos</subject><subject>Gene Expression Regulation, Neoplastic - genetics</subject><subject>Genetic aspects</subject><subject>Genotype & phenotype</subject><subject>GTP Phosphohydrolases - metabolism</subject><subject>HeLa Cells</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Invasiveness</subject><subject>Kinases</subject><subject>M Phase Cell Cycle Checkpoints - genetics</subject><subject>MCF-7 Cells</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metastases</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Microtubule-Associated Proteins - metabolism</subject><subject>Mitochondria</subject><subject>Mitochondria - genetics</subject><subject>Mitochondria - pathology</subject><subject>Mitochondrial Proteins - metabolism</subject><subject>Mitosis</subject><subject>Movement disorders</subject><subject>Neoplasm Invasiveness - genetics</subject><subject>Neurodegenerative diseases</subject><subject>Nocodazole</subject><subject>Oncology</subject><subject>original-article</subject><subject>Parkinson Disease - genetics</subject><subject>Parkinson's disease</subject><subject>Phenotypes</subject><subject>Protein Kinases - biosynthesis</subject><subject>Protein Kinases - genetics</subject><subject>Protein Kinases - metabolism</subject><subject>PTEN protein</subject><subject>Ribonucleic acid</subject><subject>Risk factors</subject><subject>RNA</subject><subject>RNA Interference</subject><subject>RNA, Small Interfering</subject><issn>0950-9232</issn><issn>1476-5594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kctu1TAQhi0EoofCqnsUqZtKkIPvsZdVVaCialmUteU4kzQlsU_tZHF2fQ1ejyfB4ZRLUYW8sDzzzfif-RE6IHhNMFPvgndriglfK_IErQivZCmE5k_RCmuBS00Z3UMvUrrBGFca0-doj3KpiBbVCnVX11B8tvFr71Pw3---paIDn0NnF59IEaGbBztBKhwMQ-G2boBiE0MXIaU--ML6ZnmP4SdjvYNY2pSC63NVTl2DD9N2A-kletbaIcGr-3sffXl_enXysTy__HB2cnxeOkmqqSSOW6vAYs2UpILjWkmnGm6Z4G3dSJbn1FzVra6VFUq3jW200gpLS0C0wPbR0a5vVnU7Q5rM2KdFvPUQ5mSIlIoKRnWV0cN_0JswR5_VGcoYkSTvi_yPyr3yIkmG_1CdHcD0vg1TtG752hxzLIlkSstMrR-h8mlg7F3w0PY5_qDgza7AxZBShNZsYj_auDUEm8V8k803i_lGLVJf30ud6xGa3-wvtzPwdgeknPIdxL9meaTfD59Ct34</recordid><startdate>20150312</startdate><enddate>20150312</enddate><creator>O'Flanagan, C H</creator><creator>Morais, V A</creator><creator>Wurst, W</creator><creator>De Strooper, B</creator><creator>O'Neill, C</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope></search><sort><creationdate>20150312</creationdate><title>The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes</title><author>O'Flanagan, C H ; Morais, V A ; Wurst, W ; De Strooper, B ; O'Neill, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c617t-1c4aa8ea093862540b86c8d4a354fbd63014948bf9b8a589fdad989806a1e5fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>692/420/755</topic><topic>692/699/67</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Cancer</topic><topic>Cell Biology</topic><topic>Cell cycle</topic><topic>Cell division</topic><topic>Cell Division - genetics</topic><topic>Cell Line, Tumor</topic><topic>Cell Movement</topic><topic>Cell proliferation</topic><topic>Cell Proliferation - genetics</topic><topic>Cell survival</topic><topic>Cellular biology</topic><topic>Chemotherapy</topic><topic>Chromosome 10</topic><topic>Clonal deletion</topic><topic>Cyclin D1</topic><topic>Cyclin D1 - biosynthesis</topic><topic>Cytokinesis</topic><topic>Cytokinesis - genetics</topic><topic>Dynamin</topic><topic>Ectopic expression</topic><topic>Embryo fibroblasts</topic><topic>Embryos</topic><topic>Gene Expression Regulation, Neoplastic - genetics</topic><topic>Genetic aspects</topic><topic>Genotype & phenotype</topic><topic>GTP Phosphohydrolases - metabolism</topic><topic>HeLa Cells</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Invasiveness</topic><topic>Kinases</topic><topic>M Phase Cell Cycle Checkpoints - genetics</topic><topic>MCF-7 Cells</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metastases</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Microtubule-Associated Proteins - metabolism</topic><topic>Mitochondria</topic><topic>Mitochondria - genetics</topic><topic>Mitochondria - pathology</topic><topic>Mitochondrial Proteins - metabolism</topic><topic>Mitosis</topic><topic>Movement disorders</topic><topic>Neoplasm Invasiveness - genetics</topic><topic>Neurodegenerative diseases</topic><topic>Nocodazole</topic><topic>Oncology</topic><topic>original-article</topic><topic>Parkinson Disease - genetics</topic><topic>Parkinson's disease</topic><topic>Phenotypes</topic><topic>Protein Kinases - biosynthesis</topic><topic>Protein Kinases - genetics</topic><topic>Protein Kinases - metabolism</topic><topic>PTEN protein</topic><topic>Ribonucleic acid</topic><topic>Risk factors</topic><topic>RNA</topic><topic>RNA Interference</topic><topic>RNA, Small Interfering</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O'Flanagan, C H</creatorcontrib><creatorcontrib>Morais, V A</creatorcontrib><creatorcontrib>Wurst, W</creatorcontrib><creatorcontrib>De Strooper, B</creatorcontrib><creatorcontrib>O'Neill, C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Oncogene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O'Flanagan, C H</au><au>Morais, V A</au><au>Wurst, W</au><au>De Strooper, B</au><au>O'Neill, C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes</atitle><jtitle>Oncogene</jtitle><stitle>Oncogene</stitle><addtitle>Oncogene</addtitle><date>2015-03-12</date><risdate>2015</risdate><volume>34</volume><issue>11</issue><spage>1363</spage><epage>1374</epage><pages>1363-1374</pages><issn>0950-9232</issn><eissn>1476-5594</eissn><coden>ONCNES</coden><abstract>PINK1 (phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-induced kinase 1), a Parkinson’s disease-associated gene, was identified originally because of its induction by the tumor-suppressor PTEN. PINK1 promotes cell survival and potentially metastatic functions and protects against cell stressors including chemotherapeutic agents. However, the mechanisms underlying PINK1 function in cancer cell biology are unclear. Here, using several model systems, we show that PINK1 deletion significantly reduced cancer-associated phenotypes including cell proliferation, colony formation and invasiveness, which were restored by human PINK1 overexpression. Results show that PINK1 deletion causes major defects in cell cycle progression in immortalized mouse embryonic fibroblasts (MEFs) from PINK1
−/−
mice, and in BE(2)-M17 cells stably transduced with short hairpin RNA against PINK1. Detailed cell cycle analyses of MEF cell lines from several PINK1
−/−
mice demonstrate an increased proportion of cells in G2/M and decreased number of cells in G1 following release from nocodazole block. This was concomitant with increased double and multi-nucleated cells, a reduced ability to undergo cytokinesis and to re-enter G1, and significant alterations in cell cycle markers, including failure to increase cyclin D1, all indicative of mitotic arrest. PINK1
−/−
cells also demonstrated ineffective cell cycle exit following serum deprivation. Cell cycle defects associated with PINK1 deficiency occur at points critical for cell division, growth and stress resistance in cancer cells were rescued by ectopic expression of human PINK1 and demonstrated PINK1 kinase dependence. The importance of PINK1 for cell cycle control is further supported by results showing that cell cycle deficits induced by PINK1 deletion were linked mechanistically to aberrant mitochondrial fission and its regulation by dynamin-related protein-1 (Drp1), known to be critical for progression of mitosis. Our data indicate that PINK1 has tumor-promoting properties and demonstrates a new function for PINK1 as a regulator of the cell cycle.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>24681957</pmid><doi>10.1038/onc.2014.81</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0950-9232 |
ispartof | Oncogene, 2015-03, Vol.34 (11), p.1363-1374 |
issn | 0950-9232 1476-5594 |
language | eng |
recordid | cdi_proquest_miscellaneous_1668253297 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Nature Journals Online; SpringerLink Journals - AutoHoldings |
subjects | 692/420/755 692/699/67 Animals Apoptosis Cancer Cell Biology Cell cycle Cell division Cell Division - genetics Cell Line, Tumor Cell Movement Cell proliferation Cell Proliferation - genetics Cell survival Cellular biology Chemotherapy Chromosome 10 Clonal deletion Cyclin D1 Cyclin D1 - biosynthesis Cytokinesis Cytokinesis - genetics Dynamin Ectopic expression Embryo fibroblasts Embryos Gene Expression Regulation, Neoplastic - genetics Genetic aspects Genotype & phenotype GTP Phosphohydrolases - metabolism HeLa Cells Human Genetics Humans Internal Medicine Invasiveness Kinases M Phase Cell Cycle Checkpoints - genetics MCF-7 Cells Medicine Medicine & Public Health Metastases Mice Mice, Knockout Microtubule-Associated Proteins - metabolism Mitochondria Mitochondria - genetics Mitochondria - pathology Mitochondrial Proteins - metabolism Mitosis Movement disorders Neoplasm Invasiveness - genetics Neurodegenerative diseases Nocodazole Oncology original-article Parkinson Disease - genetics Parkinson's disease Phenotypes Protein Kinases - biosynthesis Protein Kinases - genetics Protein Kinases - metabolism PTEN protein Ribonucleic acid Risk factors RNA RNA Interference RNA, Small Interfering |
title | The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T12%3A46%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Parkinson%E2%80%99s%20gene%20PINK1%20regulates%20cell%20cycle%20progression%20and%20promotes%20cancer-associated%20phenotypes&rft.jtitle=Oncogene&rft.au=O'Flanagan,%20C%20H&rft.date=2015-03-12&rft.volume=34&rft.issue=11&rft.spage=1363&rft.epage=1374&rft.pages=1363-1374&rft.issn=0950-9232&rft.eissn=1476-5594&rft.coden=ONCNES&rft_id=info:doi/10.1038/onc.2014.81&rft_dat=%3Cgale_proqu%3EA406163896%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1662461233&rft_id=info:pmid/24681957&rft_galeid=A406163896&rfr_iscdi=true |